Metabolic Signaling
Kathrin Thedieck
Prof. Kathrin Thedieck: joined Oldenburg University and the University Medical Center Groningen (UMCG) in 2013 in the frame of the European Medical School (EMS).
Research:
The Lab for Metabolic Signaling studies the control of metabolic homeostasis by the mammalian target of rapamycin (mTOR). We adopt cell biology, biochemistry, proteomics, and systems biology approaches. The mTOR signaling network is deregulated in a large number of tumors and is involved in aging related disorders such as metabolic and neurodegenerative diseases. mTOR kinase resides in two structurally and functionally distinct multiprotein complexes, named mTOR complex 1 (mTORC1) and mTORC2. mTORC1, in response to growth factors (insulin), nutrients (amino acids), energy (ATP), and stresses, controls growth related processes such as translation, ribosome biogenesis, and autophagy. mTORC2 is a central metabolic regulator as well, which is involved in lipid and glucose homeostasis.
Our lab analyzes the mTOR interactome and signaling by proteomic and biochemical methods (Schwarz et al., 2015). We study mTOR crosstalk with other cancer signalling ( Thien et al., 2015 ) and stress networks ( Thedieck et al. 2013 ).Systems biology approaches are adopted to unravel novel regulatory connections within the mTOR network ( Dalle Pezze et al. 2012 , Sonntag et al. 2012 ).
Alexander Heberle (PhD student)
Mirja Tamara Prentzell (PhD student)
Dr. Karen van Eunen (postdoc)
Prof. Kathrin Thedieck (lab head)
Stefanie Ruf (PhD student)
Miriam Langelaar (technician)
Patricia Razquin (PhD student)
Jorn van der Velde (student technician)
Ineke Kuper (technician)
Marti Cadena (master student)
Names indicated from left to right, and back to front.
Employment/Experience:
2013-present |
Associate Professor, Lab for Metabolic Signaling, European Medical School, University of Groningen ( NL) and Oldenburg (D) |
2008-2013 |
Group Leader Functional Proteomics of Metabolic Signaling |
2006-2008 |
Postdoctoral Fellow |
2002-2005 |
PhD Thesis and Postdoc |
2001-2002 |
Diploma Thesis and Postgraduate Scientist |
1998-2001 |
Ecole Superieure de Biotechnologie Strasbourg (ESBS) (F) |
1996-1998 |
Westfälische Wilhelms Universität Münster (D) |
Honors, Awards, and Scholarships:
- 2002-2005: Georg-Christoph-Lichtenberg Fellowship (for PhD thesis)
- 2004: Selected Helmholtz delegation member: 18th meeting of Nobel Laureates in Physics
- 2006/2007: Mentee: Women into Industry program (WIN) of Novartis and the Basel University
- 2007-2008: PostDoc Fellowship of the Peter und Traudl Engelhorn Stiftung
- 2009-2010: Schlieben-Lange Fellowship, Federal State of Baden-Württemberg
- 2013: Junior Fellowship, Freiburg Institute for Advanced Studies (FRIAS)
- 2013: Offer of a chair in Nutrigenomics, University of Hohenheim
- 2013-2018: Rosalind-Franklin-Fellowship, University of Groningen
Service to the scientific community:
- 2012-present: International Scientific Advisory Board: Int. Study Group for Systems Biology (ISGSB)
-
since 2015: Editorial Board: Pharmacological Research
Publications: |
---|
Schwarz JJ*, Wiese H*, Toelle RC, Zarei M, Dengjel J, Warscheid B°, Thedieck K°. |
Thien, A*, Prentzel, MT*, Holzwarth, B, Klaesener, K, Kuper, I, Boehlke C, Sonntag A G, Ruf S, Maerz L, Nitschke R, Grellscheid SN, Reth M, Walz G, Baumeister R, Neumann-Haefelin E° , Thedieck K° TSC1 activates TGF-β - Smad2/3 signaling in growth arrest and epithelial to mesenchymal transition. Developmental Cell, 2015 Mar 9; 32 (5):617–630. doi: 10.1016/j.devcel.2015.01.026. PubMed PMID: 25727005 [Abstract] View also the comment in Science Signaling "TSC1 strikes out on its own" Sci. Signal., 24 March 2015 Vol. 8, Issue 369, p. ec66 DOI: 10.1126/scisignal.aab1622 |
Heberle AM, Prentzell MT, van Eunen K, Bakker BM, Grellescheid SN, Thedieck K° Molecular mechanisms of mTOR regulation by stress. |
Wahane SD*, Hellbach N*, Prentzell MT*, Weise SC, Vezzali R, Kreutz C, Timmer J, Krieglstein K, Thedieck K ° , Vogel T ° . PI3K-p110-alpha-subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2. J Neurochem. 2014 Jul;130(2):255-67. doi: 10.1111/jnc.12718. Epub 2014 May 3. PubMed PMID: 24645666. [Abstract] |
Arnold CR, Pritz T, Brunner S, Knabb C, Salvenmoser W, Holzwarth B, Thedieck K ° , Grubeck-Loebenstein B ° . T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8(+)CD28(+) T cells but not in CD8(+)CD28(-) T cells. Exp Gerontol. 2014 Jun;54:75-83. doi: 10.1016/j.exger.2014.01.018. Epub 2014 Jan 24. PubMed PMID: 24468331. [Abstract] |
Thedieck K°, Holzwarth B, Prentzell MT, Boehlke C, Kläsener K, Ruf S, Sonntag AG, Maerz L, Grellscheid SN, Kremmer E, Nitschke R, Kuehn EW, Jonker JW, Groen AK, Reth M, Hall MN, Baumeister R. View also the comment in Cancer Discovery "Astrin Maintains Balanced mTORC1 Signaling under Cellular Stress" Cancer Discovery October 2013 3; OF1; Published OnlineFirst August 29, 2013; doi: 10.1158/2159-8290.CD-RW2013-191 |
Dalle Pezze P*, Sonntag AG*, Thien A, Prentzell MT, Gödel M, Fischer S, Neumann-Haefelin E, Huber TB, Baumeister R, Shanley DP°, Thedieck K°. |
View also the perspective by Diane C. Fingar and K. Inoki. "Deconvolution of mTORC2 "in Silico" |
Piero Dalle Pezze*, Annika G. Sonntag*, Daryl P. Shanley°, Kathrin Thedieck° |
Sonntag AG,* Dalle Pezze P*, Shanley DP°, Thedieck K°. |
Lankisch TO, Metzger J, Negm AA, Vosskuhl K, Schiffer E, Siwy J, Weismüller TJ, Schneider AS, Thedieck K, Baumeister R, Zürbig P, Weissinger EM, Manns MP, Mischak H, Wedemeyer J. |
Kathrin Thedieck and Michael N. Hall |
Jiang H, Schiffer E, Song Z, Wang J, Zürbig P, Thedieck K, Moes S, Bantel H, Saal N, Jantos J, Brecht M, Jenö P, Hall MN, Hager K, Manns MP, Hecker H, Ganser A, Döhner K, Bartke A, Meissner C, Mischak H, Ju Z, Rudolph KL. |
Thedieck K*, Polak P*, Kim ML, Molle KD, Cohen A, Jenö P, Arrieumerlou C, Hall MN. |
Thedieck K*, Hain T*, Mohamed W, Tindall BJ, Nimtz M, Chakraborty T, Wehland J, Jänsch L. |
*equally contributing °corresponding author |
Patents:
- K Thedieck, AG Sonntag, P Dalle Pezze, DP Shanley. Method for modeling, optimizing, parameterizing, testing and/or validating a dynamic network or network perturbation. Priority date June 1 2011 (Publication n° WO2012163440).
-
K Thedieck, B Holzwarth, R. Baumeister. Modulators of the interaction of astrin and raptor, and uses thereof in cancer therapy. Priority date Jan. 11 2013 (Publication n° WO2014108532).
Links: |
---|
|
Last modified: | 13 December 2021 12.04 p.m. |